FDA inspection
Purdue Pharma, L.P.: FDA inspection ending Dec 6, 2016
FDA inspection 994812 · Voluntary Action Indicated (VAI) · Stamford, CT
Key facts
| Inspection ID | 994812 |
|---|---|
| Firm | Purdue Pharma, L.P. |
| FEI number | 3004365793 |
| Address | 201 Tresser Blvd |
| City | Stamford |
| State | CT |
| ZIP | 06901-3435 |
| Fiscal year | 2017 |
| Inspection end date | Dec 6, 2016 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Drug Quality Assurance|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs|Post Mrkt Surv & Epid: Human Drugs|Postmarketing Surveillance and Epidemiology: Human Drugs |
| Product type | Drugs |
At a glance
- 1–9 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data